Loading clinical trials...

Assessing Normal Multichannel Intraluminal Impedance (MII)-pH Parameters for Today's Population | Clinical Trials | Clareo Health

Back to clinical trial search

TERMINATEDNANCT01566383

Assessing Normal Multichannel Intraluminal Impedance (MII)-pH Parameters for Today's Population

The normal values of a Multichannel Intraluminal Impedance (MII)-pH study can vary between ages, gender, race and different values of body mass index (BMI). This fact can cause new modifications in th...

Lead sponsor: Vanderbilt University Medical Center•2 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Trial snapshot

StatusTERMINATED

PhaseNA

Enrollment19

Start dateMar 2012

Last updatedFeb 23, 2017

Condition

Identify Normal MII-pH Parameters

Locations shown

Vanderbilt University Medical Center

Nashville, Tennessee

Vanderbilt University Medical Center

Nashville, Tennessee

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 23, 2017Data synced to Clareo: May 17, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions